GSK 241129 35.00P (GSK241129P35000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

GSK241129P35000

Watchlist

0.84
-0.17-16.83%

15min DelayClose Nov 27 16:00 ET

0.84High0.84Low

Intraday

5D
Daily

News

European Commission Approves Products by BeiGene, GSK and Novartis
Seeking AlphaNov 27 08:41 ET
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Seeking AlphaNov 27 06:23 ET
Express News | GSK's Fully Liquid Menveo Meningococcal Vaccine Approved By European Commission
BenzingaNov 27 06:17 ET
GSK's Liquid Meningitis Vaccine Gets EU Authorization
WSJNov 27 02:22 ET
Bird Flu Found In Raw Milk Leads To Recall In California
BenzingaNov 26 13:07 ET
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
BenzingaNov 26 10:29 ET

Comments

corbotron

Oct 10 09:25

I hope these bullies get decimated

$Pfizer (PFE.US)$ destroyed the shareholder confidence again. company isn't interested in shareholder value. latest threat of legal action against the former executives shows the company has no intention of curbing their careless cash spend. it's gone from creating value for shareholders to taking value from shareholders. bullies thinking they can do what they want with no repercussions. I hope their share price gets decimated over their poor decision to use forc...

Moomoo Breakfast US

Oct 10 06:53

Columns US Morning News Call | U.S. Stock Futures Drop Ahead of Key Inflation Report; Tesla Robotaxi Event Catches Attention

Expand

Tesla's "Cybercab" global debut sends stock falling

corbotron

Oct 9 15:33

$Pfizer (PFE.US)$ another positive, keep an eye $GlaxoSmithKline (GSK.US)$ $Apple (AAPL.US)$ $

Pfizer Inc - Declares $0.42 Fourth-Quarter 2024 Dividend

corbotron

Oct 9 15:07

$Pfizer (PFE.US)$ definitely an opportunity here to catch the rise, CEO will be meeting next week with new investor. discussions on directions will most likely be on the table and trimming the fat of recent acquisitions. speculation is making this stock rise until the news from the meeting is released. it's looking like there is more in the rumor mill and the price is reflecting it over the last couple sessions. keep an eye $Apple (AAPL.US)$ $Novo-Nordisk A/S (NVO.US)$ $GlaxoSmithKline (GSK.US)$

corbotron

Oct 9 12:29

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$